Approval · Notice of Compliance 3129 · 1998
APO-PRAZO: Notice of Compliance 3129
Issued March 13, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3129
- Date
- March 13, 1998
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised product monograph and labelling
- Therapeutic class
- Antihypertensive agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APO-PRAZO | Not yet assigned | — |
Medicinal ingredients
- PRAZOSIN HCL 1 MG per TAB
- PRAZOSIN HCL 2 MG per TAB
- PRAZOSIN HCL 5 MG per TAB